Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Telomerase-specific CTL from tumor-bearing patients are spared functional inactivation due to immunologic ignorance

Vonderheide, R.H., Schultze, J.L., Anderson, K.S., Maecker, B., Butler, M.O., von Bergwelt-Baildon, M.S., Wucherpfennig, K.W., Hahn, W.C., Nadler, L.M. Telomerase-specific CTL from tumor-bearing patients are spared functional inactivation due to immunologic ignorance. Annual Meeting of the American Society of Hematology. 2000.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.